Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
GARY J SCHILLER
Listed Specialty: Hematology & Oncology
200 MEDICAL PLAZA, #365,530,420,120, LOS ANGELES, CA, 90095
GARY SCHILLER,
Yearly Payment Breakdown:
2018 Payments At a Glance
47
payments
$52,719
payment total
15
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
Category | Payments | Payment Value |
---|---|---|
Promotional Speaking/Other |
20 | $36,397 |
Consulting |
9 | $13,589 |
Travel and Lodging |
6 | $1,945 |
Food and Beverage |
12 | $789 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
Product Name | Product Type | Payments† |
---|---|---|
ISATUXIMAB |
drug |
$13,034 |
REVLIMID |
drug |
$12,316 |
KYPROLIS |
drug |
$6,255 |
NO PRODUCT DISCUSSED |
drug |
$4,780 |
VYXEOS |
drug |
$4,369 |
IMBRUVICA |
drug |
$3,635 |
Payments with no listed product |
N/A |
$2,357 |
TIBSOVO |
drug |
$1,388 |
DAURISMO |
drug |
$1,270 |
POMALYST |
drug |
$1,082 |
JAKAFI |
drug |
$923 |
YESCARTA |
drug |
$750 |
BLINCYTO |
drug |
$550 |
PREVYMIS |
drug |
$13 |
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. |
Payment Details in 2018
When | How Much | Related To | What For | From | Third Party Payee |
---|---|---|---|---|---|
Jul 12, 2018 | $4,780 | NO PRODUCT DISCUSSED | Promotional Speaking/Other | SANOFI US SERVICES INC. | |
Apr 5, 2018 | $3,500 | VYXEOS | Promotional Speaking/Other | JAZZ PHARMACEUTICALS INC. | |
Sep 7, 2018 | $3,300 | KYPROLIS | Promotional Speaking/Other | AMGEN INC. | |
Sep 21, 2018 | $2,896 | ISATUXIMAB | Consulting | SANOFI-AVENTIS U.S. LLC | |
Oct 23, 2018 | $2,750 | IMBRUVICA | Promotional Speaking/Other | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Mar 8, 2018 | $2,625 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Feb 20, 2018 | $2,625 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Aug 28, 2018 | $2,625 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Oct 10, 2018 | $2,607 | ISATUXIMAB | Consulting | SANOFI-AVENTIS U.S. LLC | |
Feb 6, 2018 | $2,400 | KYPROLIS | Promotional Speaking/Other | AMGEN INC. | |
Dec 1, 2018 | $2,190 | No Listed Product | Promotional Speaking/Other | ASTELLAS PHARMA US INC | |
Aug 28, 2018 | $1,925 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Jun 7, 2018 | $1,738 | ISATUXIMAB | Consulting | SANOFI-AVENTIS U.S. LLC | |
May 25, 2018 | $1,738 | ISATUXIMAB | Consulting | SANOFI-AVENTIS U.S. LLC | |
May 25, 2018 | $1,304 | ISATUXIMAB | Consulting | SANOFI-AVENTIS U.S. LLC | |
Jun 6, 2018 | $1,304 | ISATUXIMAB | Consulting | SANOFI-AVENTIS U.S. LLC | |
Dec 2, 2018 | $1,082 | POMALYST | Promotional Speaking/Other | CELGENE CORPORATION | |
Dec 4, 2018 | $940 | DAURISMO | Promotional Speaking/Other | PFIZER INC. | |
Aug 24, 2018 | $923 | JAKAFI | Promotional Speaking/Other | INCYTE CORPORATION | |
Aug 28, 2018 | $837 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
Sep 6, 2018 | $833 | TIBSOVO | Promotional Speaking/Other | AGIOS PHARMACEUTICALS, INC. | |
Mar 8, 2018 | $770 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Apr 5, 2018 | $763 | VYXEOS | Travel and Lodging | JAZZ PHARMACEUTICALS INC. | |
Jun 14, 2018 | $750 | YESCARTA | Promotional Speaking/Other | KITE PHARMA, INC. | |
Jul 26, 2018 | $750 | IMBRUVICA | Promotional Speaking/Other | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Feb 28, 2018 | $750 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Sep 28, 2018 | $724 | ISATUXIMAB | Consulting | SANOFI-AVENTIS U.S. LLC | |
Jan 26, 2018 | $724 | ISATUXIMAB | Consulting | SANOFI-AVENTIS U.S. LLC | |
Nov 1, 2018 | $555 | TIBSOVO | Consulting | AGIOS PHARMACEUTICALS, INC. | |
Apr 16, 2018 | $550 | BLINCYTO | Promotional Speaking/Other | AMGEN INC. | |
Aug 31, 2018 | $333 | KYPROLIS | Travel and Lodging | AMGEN INC. | |
Jul 31, 2018 | $330 | DAURISMO | Promotional Speaking/Other | PFIZER INC. | |
Feb 20, 2018 | $134 | REVLIMID | Food and Beverage | CELGENE CORPORATION | |
Aug 30, 2018 | $119 | KYPROLIS | Food and Beverage | AMGEN INC. | |
Oct 23, 2018 | $117 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Apr 5, 2018 | $106 | VYXEOS | Food and Beverage | JAZZ PHARMACEUTICALS INC. | |
Jan 25, 2018 | $94 | KYPROLIS | Food and Beverage | AMGEN INC. | |
Nov 30, 2018 | $62 | No Listed Product | Food and Beverage | DAIICHI SANKYO INC. | |
Dec 6, 2018 | $43 | No Listed Product | Food and Beverage | CELGENE CORPORATION | |
Dec 1, 2018 | $40 | No Listed Product | Food and Beverage | JANSSEN RESEARCH & DEVELOPMENT, LLC | |
Aug 21, 2018 | $25 | REVLIMID | Food and Beverage | CELGENE CORPORATION | |
Dec 3, 2018 | $22 | No Listed Product | Food and Beverage | ASTRAZENECA PHARMACEUTICALS LP | |
Feb 25, 2018 | $15 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Feb 24, 2018 | $13 | PREVYMIS | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
Jan 30, 2018 | $8 | KYPROLIS | Travel and Lodging | AMGEN INC. | |
Oct 23, 2018 | $3 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Jan 30, 2018 | $1 | KYPROLIS | Travel and Lodging | AMGEN INC. |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.